Generate Investment Management Ltd grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 1,125.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 135,000 shares of the healthcare conglomerate's stock after buying an additional 123,987 shares during the quarter. UnitedHealth Group accounts for about 2.3% of Generate Investment Management Ltd's holdings, making the stock its 10th biggest position. Generate Investment Management Ltd's holdings in UnitedHealth Group were worth $42,116,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Forefront Wealth Management Inc. lifted its stake in UnitedHealth Group by 3.1% during the 2nd quarter. Forefront Wealth Management Inc. now owns 4,741 shares of the healthcare conglomerate's stock valued at $1,479,000 after acquiring an additional 144 shares in the last quarter. Lazari Capital Management Inc. boosted its holdings in UnitedHealth Group by 271.7% during the second quarter. Lazari Capital Management Inc. now owns 3,464 shares of the healthcare conglomerate's stock worth $1,081,000 after purchasing an additional 2,532 shares during the last quarter. Smith Salley Wealth Management increased its stake in UnitedHealth Group by 99.8% in the 2nd quarter. Smith Salley Wealth Management now owns 6,794 shares of the healthcare conglomerate's stock valued at $2,120,000 after buying an additional 3,394 shares during the last quarter. City Holding Co. boosted its stake in shares of UnitedHealth Group by 24.2% in the 2nd quarter. City Holding Co. now owns 15,863 shares of the healthcare conglomerate's stock worth $4,948,000 after buying an additional 3,088 shares during the last quarter. Finally, Camelot Portfolios LLC lifted its holdings in UnitedHealth Group by 180.5% during the second quarter. Camelot Portfolios LLC now owns 2,412 shares of the healthcare conglomerate's stock worth $753,000 after acquiring an additional 1,552 shares during the period. 87.86% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
UNH has been the subject of a number of research reports. JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research report on Wednesday, August 6th. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research report on Tuesday, September 9th. Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research note on Monday, August 18th. Barclays increased their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Finally, Sanford C. Bernstein upped their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $358.95.
Read Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Down 0.4%
UNH stock opened at $344.15 on Monday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a 50-day moving average of $301.20 and a two-hundred day moving average of $358.73. The company has a market cap of $311.69 billion, a price-to-earnings ratio of 14.91, a PEG ratio of 2.24 and a beta of 0.44. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period last year, the company earned $6.80 EPS. The business's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is presently 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.